Medicine,
Journal Year:
2022,
Volume and Issue:
101(49), P. e32100 - e32100
Published: Dec. 9, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
causing
disease
(COVID-19),
has
been
devastated
by
COVID-19
in
an
increasing
number
of
countries
and
health
care
systems
around
the
world
since
its
announcement
a
global
pandemic
on
11
March
2020.
During
pandemic,
emerging
novel
viral
mutant
variants
have
caused
multiple
outbreaks
are
prone
to
genetic
evolution,
serious
damage
human
health.
As
confirmed
cases
spread
rapidly,
there
is
evidence
that
SARS-CoV-2
infection
involves
central
nervous
system
(CNS)
peripheral
(PNS),
directly
or
indirectly
damaging
neurons
further
leading
neurodegenerative
diseases
(ND),
but
molecular
mechanisms
ND
CVOID-19
unknown.
We
employed
transcriptomic
profiling
detect
several
major
ND:
Alzheimer
's
(AD),
Parkinson'
s
(PD),
sclerosis
(MS)
common
pathways
biomarkers
association
with
COVID-19,
helping
understand
link
between
COVID-19.
There
were
14,
30
19
differentially
expressed
genes
(DEGs)
(PD)
(MS),
respectively;
enrichment
analysis
showed
MAPK,
IL-17,
PI3K-Akt
other
signaling
significantly
expressed;
hub
(HGs)
DEGs
CRH,
SST,
TAC1,
SLC32A1,
GAD2,
GAD1,
VIP
SYP.
Analysis
transcriptome
data
suggests
co-morbid
AD,
PD,
MS,
providing
new
ideas
therapeutic
strategies
for
clinical
prevention
treatment
ND.
Pharmacological Reviews,
Journal Year:
2024,
Volume and Issue:
76(5), P. 896 - 914
Published: June 12, 2024
Drug
targets
are
specific
molecules
in
biological
tissues
and
body
fluids
that
interact
with
drugs.
target
discovery
is
a
key
component
of
drug
essential
for
the
development
new
drugs
areas
such
as
cancer
therapy
precision
medicine.
Traditional
in
vitro
or
vivo
methods
time-consuming
labour-intensive,
limiting
pace
discovery.
With
modern
methods,
application
various
emerging
technologies
have
greatly
improved
efficiency
discovery,
shortened
cycle
time
reduced
cost.
This
review
provides
comprehensive
overview
strategies,
including
computer-assisted
approaches,
affinity
response
stability,
multiomics
analysis,
gene
editing,
NMD,
discusses
effectiveness
limitations
well
their
real
cases.
Through
above
related
contents,
general
novel
disease
treatment
strategies
will
be
provided,
theoretical
basis
provided
those
who
engaged
pharmaceutical
science
research.
Significance
Statement
Target-based
has
been
main
approach
to
industry
past
three
decades.
based
on
or
validation
costly,
Therefore,
selection
process
crucial.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(1), P. e0313743 - e0313743
Published: Jan. 14, 2025
Background
Fracture
disrupts
the
integrity
and
continuity
of
bone,
leading
to
symptoms
such
as
pain,
tenderness,
swelling,
bruising.
Rhizoma
Musae
is
a
medicinal
material
frequently
utilized
in
Miao
ethnic
region
Guizhou
Province,
China.
However,
its
specific
mechanism
action
treating
fractures
remains
unknown.
This
study
aimed
elucidate
chemical
constituents
ethanol
extract
(EERM)
investigate
fracture-healing
using
network
pharmacology.
Methods
The
profile
EERM
was
characterized
via
UHPLC-Q-Exactive-MS/MS.
Subsequently,
comprehensive
compounds,
targets,
pathways
constructed
pharmacology
approaches.
interactions
between
active
compounds
their
targets
were
validated
through
molecular
docking,
dynamics
simulation
vitro
cell
experiments.
Results
contained
522
identified
compounds.
Topological
analysis
protein-protein
interaction
(PPI)
59
core
including
key
proteins
like
AKT1,
IL-6,
EGFR,
known
for
anti-inflammatory
properties
ability
enhance
bone
proliferation
differentiation.
Gene
Ontology
indicated
involvement
biological
processes
peptidyl-serine
phosphorylation,
response
xenobiotic
stimulus,
nutrient
level
regulation.
KEGG
suggested
that
EERM’s
may
involve
signaling
PI3K-Akt,
lipid
atherosclerosis,
EGFR
tyrosine
kinase
inhibitor
resistance,
MAPK
pathways.
Molecular
docking
simulations
results
demonstrated
strong
binding
affinity
main
targets.
In
experiments
demonstrate
enhances
by
upregulating
expression
levels
STAT3,
while
simultaneously
downregulating
AKT1
CASP3.
Conclusion
investigates
potential
regulating
multiple
fracture,
promoting
proliferation.
These
offer
valuable
insights
future
development
clinical
application
Musae.
Journal of Ethnopharmacology,
Journal Year:
2023,
Volume and Issue:
322, P. 117610 - 117610
Published: Dec. 19, 2023
The
QiShengYiQi
pill
(QSYQ)
is
a
traditional
Chinese
medicinal
formulation.
effectiveness
and
safety
of
QSYQ
in
treating
respiratory
system
disorders
have
been
confirmed.
Its
pharmacological
actions
include
anti-inflammation,
antioxidative
stress,
improving
energy
metabolism.
However,
the
mechanism
sepsis-induced
acute
lung
injury
(si-ALI)
remains
unclear.
Si-ALI
presents
clinical
challenge
with
high
incidence
mortality
rates.
This
study
aims
to
confirm
efficacy
si-ALI
explore
potential
mechanisms,
providing
scientific
foundation
for
its
application
insights
optimizing
treatment
strategies
identifying
active
components.
impact
on
was
evaluated
using
cecal
ligation
puncture
(CLP)
experimental
sepsis
animal
model.
effects
endothelial
cells
were
observed
through
coculturing
LPS-stimulated
macrophage-conditioned
medium.
Inflammatory
cytokine
levels,
HE
staining,
Evans
blue
wet/dry
ratio,
cell
count
protein
content
bronchoalveolar
lavage
fluid
used
assess
degree
injury.
Network
pharmacology
utilized
investigate
mechanisms
si-ALI.
Western
blot
immunofluorescence
analyses
evaluate
barrier
integrity
validate
mechanistically
relevant
proteins.
reduced
inflammation
alleviated
pulmonary
vascular
damage
CLP
mice
(all
P
<
0.05).
A
total
127
targets
which
regulates
identified,
predominantly
enriched
RAGE
pathway.
results
protein-protein
interaction
analysis
suggest
that
COX2,
well-established
critical
marker
ferroptosis,
among
key
targets.
In
vitro
vivo
studies
demonstrated
mitigated
ferroptosis
0.05),
accompanied
by
reduction
oxidative
stress
inhibition
COX2
maintains
inhibiting
mice.
These
findings
partially
elucidate
further
clarify
components
QSYQ,
thereby
theoretical
basis
QSYQ.